Rescue of polyglutamine-mediated cytotoxicity by doulble-stranded RNA-mediated RNA interference

Human Molecular Genetics

Volumn 11, Issue 2, 2002, Pages 175-184

  Caplen, Natasha J ^a   Taylor, J Paul ^b   Statham, Victoria S ^a   Tanaka, Fumiaki ^b   Fire, Andrew ^c   Morgan, Richard A ^a,d  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEOPHYSICAL LABORATORY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; CASPASE 3; CYTOSINE; DOUBLE STRANDED RNA; GUANINE; NUCLEOTIDE; POLYGLUTAMINE;

ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOMINANT INHERITANCE; DOWN REGULATION; DROSOPHILA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC CODE; GENETIC DISORDER; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; RNA TRANSCRIPTION; SPINAL MUSCULAR ATROPHY; TISSUE CULTURE; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DROSOPHILA; FEASIBILITY STUDIES; GENE SILENCING; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MUSCULAR DISORDERS, ATROPHIC; PEPTIDES; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; RNA; RNA, DOUBLE-STRANDED; TRINUCLEOTIDE REPEATS;

ANIMALIA; MAMMALIA;

EID: 0037081772     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Post-transcriptional gene silencing across kingdoms
2. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
3. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans
4. Specific interference with gene function by double-stranded RNA in early mouse development
5. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference
6. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
7. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
8. RNAi-prospects for a general technique for determining gene function
9. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway
10. Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): A role for nautilus in embryonic somatic muscle formation
11. Suppression of gene expression by targeted disruption of messenger RNA: Available options and current strategies
12. Fourteen and counting: Unraveling trinucleotide repeat diseases
13. Triplet repeat expansion in neuromuscular disease
14. Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold
15. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy
16. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy
17. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
18. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
19. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
20. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
21. Spinobulbar muscular atrophy: Polyglutamine-expanded androgen receptor is proteolytically resistant in vitro and processed abnormally in transfected cells
22. Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy
23. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy
24. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
25. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
26. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract
27. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo
28. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and vivo
29. A cellular model that recapitulates major pathogenic steps of Huntington's disease
30. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
31. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila
32. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
33. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
34. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner
35. Kennedy's disease: Caspase cleavage of the androgen receptor is a crucial event in cytotoxicity
36. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain
37. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
38. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
39. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
40. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
41. Genetic suppression of polyglutamine toxicity in Drosophila
42. Caspase-8 is required for cell death induced by expanded polyglutamine repeats
43. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
44. Antisense therapeutics: Is it as simple as complementary base recognition?
45. Ribozymes and the anti-gene therapy: How a catalytic RNA can be used to inhibit gene function
46. Catalytic nucleic acids: From lab to applications
47. Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence
48. Inhibition of Huntington synthesis by antisense oligodeoxynucleotides
49. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa
50. Strategems in vitro for gene therapies directed to dominant mutations
51. dsRNA-mediated gene silencing in cultured Drosophila cells: A tissue culture model for the analysis of RNA interference
52. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways
53. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells
54. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons
55. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
56. A genetic model for human polyglutamine-repeat disease in Drosophila melanogaster
57. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
58. Functional anatomy of a dsRNA trigger. Differential requirement for the two trigger strands in RNA interference
59. RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
60. Targeted mRNA degradation by double-stranded RNA in vitro
61. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos
62. The double-stranded RNA-dependent protein kinase PKR: Structure and function
63. Role for a bidentate ribonuclease in the initiation step of RNA interference
64. RNA silencing in plants-defense and counterdefense
65. RNA: Guiding gene silencing
66. Genome-wide RNAi
67. A species of small antisense RNA in posttranscriptional gene silencing in plants
68. RNA interference is mediated by 21- and 22-nucleotide RNAs